ADBICA
Encyclopedic
Encyclopedic
Typical encyclopedia coverage. Cross-reference for important decisions.
- 3 corroborating sources
- 2 ROAs with full dose ladders
- duration data present
- 16 combo interactions documented
- classified Research-chemical
- dose data not in PW/TripSit (unverifiable)
- 3 corroborating sources
- 2 ROAs with full dose ladders
- duration data present
- 16 combo interactions documented
- classified Research-chemical
- dose data not in PW/TripSit (unverifiable)
Aliases: Adb-pica
Summary
ADBICA is a highly potent full agonist at CB1 and CB2 receptors, significantly stronger than delta-9-THC. Because batches are often mis-weighed or sprayed unevenly on herbal material, accidental overdose is common and has been linked to acute psychosis, seizures, tachyarrhythmia, kidney injury and death. Begin with micro-doses carefully weighed on a 0.001 g scale.
Dose Information
Dose basis. Dose data for ADBICA are not from clinical trials; they come predominantly from forensic detections and community reports of similarly potent indole/indazole carboxamide SCRAs. Potency can be sub‑milligram; do not eyeball. Prefer volumetric dosing (dissolve a weighed amount in a known volume of ethanol/PG and measure by volume). Community harm-reduction discussions emphasize that cheap mg scales are unreliable under ~20 mg; use a calibrated 0.001 g scale and make a dilute solution to measure safer sub‑mg portions. Synthetic-cannabinoid blends can contain “hot spots” from uneven spraying—avoid home‑spraying plant material; use measured solutions instead. Citations: Erowid ‘Spice & spin‑offs’ notes microgram‑range potency; Bluelight volumetric dosing thread; Reddit discussion on mg‑scale accuracy limits; Erowid note on variability of packaged ‘spice’ products. Oral onset is delayed and peaks later than smoked; avoid redosing for at least 2–3 hours to prevent accidental overdose. As with smoked use, rely on volumetric dosing and an accurate scale; do not ‘eyeball’. Citations: general dosing caution from Erowid ‘Dose’; community volumetric dosing guidance on Bluelight. (Dose figures and this note are from Drugs.Wiki.)
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Smoked | 0.25-0.5mg | 0.5-1mg | 1-1.5mg | 1.5mg+ |
| Oral | 0.3-0.6mg | 0.6-1.2mg | 1.2-2mg | 2mg+ |
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | Total |
|---|---|---|---|---|
| Smoked | 1-2 min | 5-30 min | 60 min | 1.09-1.53 hrs |
| Oral | 30-60 min | 1-3 hrs | 2 hrs | 3.5-6 hrs |
Effect Profile
Scores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Mild headspace, auditory effects, and body load with low visuals
Add to PsychonautWiki Journal
The PsychonautWiki Journal logging app doesn't include every substance. To track ADBICA there, start adding an ingestion, search for the name, and choose to add it as a custom substance. Paste these values:
ADBICA Source: SubstanceSearch (substancesearch.com) Smoked dose (mg): threshold 0.25 · light 0.25-0.5 · common 0.5-1 · strong 1-1.5 · heavy 1.5+ Oral dose (mg): threshold 0.3 · light 0.3-0.6 · common 0.6-1.2 · strong 1.2-2 · heavy 2+ Smoked duration: onset 1-2m · peak 5-30m · offset 1h · total 1.09-1.53h · after-effects 1-3h Oral duration: onset 0.5-1h · peak 1-3h · offset 2h · total 3.5-6h · after-effects 1-3h Note: ranges are harm-reduction guidance, not a prescription. Start low, go slow, and test your substances.
Tip: for quicker logging you can also add a Custom Unit in the app, e.g. common dose ~ 0.75 mg (Smoked).
The app keeps custom substances simple, so the full dose ranges live in the description text above. Ranges are harm-reduction guidance, not a prescription.
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session — the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Daily/frequent SCRA use rapidly builds tolerance and blunts cannabis effects for weeks after cessation per clinical observations and community reports; recovery typically requires several weeks’ abstinence. Data quality is limited and inter‑individual variability is high.
Cross-Tolerances
Effects
- Pain relief
- Stimulation
- Dry mouth
- Tachycardia
- Nausea/vomiting
- Strong dysphoria on comedown
- Nausea
- Red eyes
- Spontaneous bodily sensations
- Vasodilation
- Euphoria
- Thought connectivity
- Mindfulness
- Conceptual thinking
- Anxiety
- Paranoia
- Rapid, intense intoxication
- Anxiolysis or severe anxiety/panic
- Time distortion
- Dissociation at high doses
- Increased music appreciation
- Auditory acuity enhancement
- Dehydration
- Visual sharpening or mild pseudo-hallucinations
- Dulled perception
- Auditory distortion
- Changes in felt gravity
- Perception of bodily heaviness
- Appetite intensification
- Drifting
Combinations
Cross-Check ADBICA with another substanceHelpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for ADBICA? Let us know. Reports are reviewed by moderators — this is not posted publicly.